Investor directory

Starry Pharmaceutical

Zhejiang Starry Pharmaceutical Co., Ltd., established in 1997, is a Chinese high-tech enterprise specializing in the research, development, manufacturing, and marketing of active ingredients and intermediates for X-ray computed tomography (CT) non-ionic contrast agents and fluoroquinolones. Its product portfolio includes various contrast mediums like iohexol, ioversol, iopamidol, and gadopentetate dimeglumine, as well as fluoroquinolones such as levofloxacin and pazufloxacin. The company operates both domestically and internationally.
http://www.starrypharm.com
https://crunchbase.com/organization/zhejiang-starry-pharmaceutical
https://linkedin.com/company/zhejiang-starry-pharmaceutical-co.-ltd
https://www.capitaliq.com/CIQDotNet/company.aspx?companyId=52297113

Weiyi Shen

General Manager and Vice Chairman

1 past transactions

Yannuo Pharmaceutical

Series A in 2023
Yannuo Pharmaceutical is a high-tech enterprise focusing on the research and development of complex injections. It has three main drug research and development technology platforms: liposomes, nanoparticles, and microspheres. Relying on the advanced drug delivery technology platform, the company adheres to the clinical needs-oriented and conducts research and development of small molecule drugs, nucleic acid drugs, peptides, and protein drugs. Deepen development and industrialization, focusing on the tumor, contrast agents, anesthesia and pain, and other therapeutic areas.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.